Zhang, Ling
Zhang, Honggeng
Lv, Lu-xian
Tan, Qingrong
Xu, Xiufeng
Hu, Jian
Zi, Lu
Cooper, James
Phansalkar, Abhay
Wang, Gang
Clinical trials referenced in this document:
Documents that mention this clinical trial
A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of lamotrigine in the maintenance treatment of Chinese adult patients with bipolar I disorder
https://doi.org/10.1186/s40345-022-00266-4
Funding for this research was provided by:
GSK (113783)
Article History
Received: 14 October 2021
Accepted: 23 June 2022
First Online: 1 August 2022
Declarations
:
: The study protocol was approved by an Independent Ethics Committee or Institutional Review Board at each study centre. Written informed consent was obtained from each participant prior to any study-specific procedures.
: Not applicable.
: Lu Zi is an employee of GlaxoSmithKline. James Cooper and Abhay Phansalkar are employees of, and hold stocks in, GlaxoSmithKline. All other authors declare that they have no conflicts of interest.